Clinical Trial Update: Study in Healthy Tubal Ligated Women to Evaluate Pharmacodynamics, Safety and Pharmacokinetics of BAY1002670 [Phase 1]

View source ↗

Summary

This Phase 1 study in healthy tubal-ligated women assessed the pharmacodynamics, safety, and pharmacokinetics of BAY1002670 in relation to uterine fibroids.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Uterine Fibroids

Drugs mentioned

• BAY1002670

Snippet

Sponsor: Bayer | Conditions: Leiomyoma | Phase 1 | Status: COMPLETED